» Articles » PMID: 25449784

Cancer Cells Remodel Themselves and Vasculature to Overcome the Endothelial Barrier

Overview
Journal Cancer Lett
Specialty Oncology
Date 2014 Dec 3
PMID 25449784
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Metastasis refers to the spread of cancer cells from a primary tumor to distant organs mostly via the bloodstream. During the metastatic process, cancer cells invade blood vessels to enter circulation, and later exit the vasculature at a distant site. Endothelial cells that line blood vessels normally serve as a barrier to the movement of cells into or out of the blood. It is thus critical to understand how metastatic cancer cells overcome the endothelial barrier. Epithelial cancer cells acquire increased motility and invasiveness through epithelial-to-mesenchymal transition (EMT), which enables them to move toward vasculature. Cancer cells also express a variety of adhesion molecules that allow them to attach to vascular endothelium. Finally, cancer cells secrete or induce growth factors and cytokines to actively prompt vascular hyperpermeability that compromises endothelial barrier function and facilitates transmigration of cancer cells through the vascular wall. Elucidation of the mechanisms underlying metastatic dissemination may help develop new anti-metastasis therapeutics.

Citing Articles

Cancer cells impact the microrheology of endothelial cells during physical contact or through paracrine signalling.

Kefala G, Tsvirkun D, Laurent V, Verdier C Sci Rep. 2025; 15(1):8064.

PMID: 40055419 PMC: 11889160. DOI: 10.1038/s41598-025-92422-w.


ATXN3 deubiquitinates ZEB1 and facilitates epithelial-mesenchymal transition in glioblastoma.

Wei R, Shi X, Qiu W, Yang M, Chen Y, Song S Sci Rep. 2025; 15(1):7868.

PMID: 40050358 PMC: 11885642. DOI: 10.1038/s41598-025-92317-w.


Single-cell sequencing reveals cell heterogeneity and aberrantly activated pathways associated with microvascular invasion in hepatocellular carcinoma.

Cui J, Zeng F, Tang M, Yin S Front Cell Dev Biol. 2025; 13:1449624.

PMID: 39944086 PMC: 11814199. DOI: 10.3389/fcell.2025.1449624.


Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy.

Shao X, Zhao X, Wang B, Fan J, Wang J, An H Theranostics. 2025; 15(5):1689-1714.

PMID: 39897552 PMC: 11780529. DOI: 10.7150/thno.103636.


Serum from Hypertensive Patients Induces Cancer-Supporting Phenotype of Vascular Endothelium In Vitro.

Uruski P, Mikula-Pietrasik J, Tykarski A, Ksiazek K Biomolecules. 2024; 14(11).

PMID: 39595551 PMC: 11592052. DOI: 10.3390/biom14111374.


References
1.
Aoyama D, Hashimoto N, Sakamoto K, Kohnoh T, Kusunose M, Kimura M . Involvement of TGFβ-induced phosphorylation of the PTEN C-terminus on TGFβ-induced acquisition of malignant phenotypes in lung cancer cells. PLoS One. 2013; 8(11):e81133. PMC: 3838341. DOI: 10.1371/journal.pone.0081133. View

2.
Cui Y, Yamada S . N-cadherin dependent collective cell invasion of prostate cancer cells is regulated by the N-terminus of α-catenin. PLoS One. 2013; 8(1):e55069. PMC: 3554680. DOI: 10.1371/journal.pone.0055069. View

3.
Klemm F, Bleckmann A, Siam L, Chuang H, Rietkotter E, Behme D . β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis. Carcinogenesis. 2010; 32(3):434-42. DOI: 10.1093/carcin/bgq269. View

4.
Potenta S, Zeisberg E, Kalluri R . The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer. 2008; 99(9):1375-9. PMC: 2579683. DOI: 10.1038/sj.bjc.6604662. View

5.
Ito Y, Oike Y, Yasunaga K, Hamada K, Miyata K, Matsumoto S . Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. Cancer Res. 2003; 63(20):6651-7. View